Full text is available at the source.
Abstract
Reduced GLUT1 expression in Alzheimer's disease brains is associated with impaired cerebral glucose uptake.
- Alzheimer's disease is characterized by progressive cognitive decline and is prevalent in the aging population.
- Traditional models of Alzheimer's disease pathogenesis have failed to provide definitive therapeutic breakthroughs.
- Emerging research indicates that metabolic dysfunction, particularly in glucose transport, may play a central role in the progression of Alzheimer's disease.
- GLUT1 is essential for glucose transport across the blood-brain barrier and maintaining brain energy metabolism.
- Alterations in GLUT1 expression are linked to neuronal dysfunction and neurodegeneration in Alzheimer's disease.
- Potential therapeutic strategies to restore GLUT1 function include gene therapy, ketogenic diets, and small molecules that enhance GLUT1 expression.
Simplified